CN115671001B - Whitening and skin brightening essence and preparation method thereof - Google Patents
Whitening and skin brightening essence and preparation method thereof Download PDFInfo
- Publication number
- CN115671001B CN115671001B CN202211470574.6A CN202211470574A CN115671001B CN 115671001 B CN115671001 B CN 115671001B CN 202211470574 A CN202211470574 A CN 202211470574A CN 115671001 B CN115671001 B CN 115671001B
- Authority
- CN
- China
- Prior art keywords
- extract
- whitening
- skin
- parts
- essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 73
- 238000005282 brightening Methods 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 80
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 46
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims abstract description 46
- 229940112950 sage extract Drugs 0.000 claims abstract description 29
- 235000020752 sage extract Nutrition 0.000 claims abstract description 29
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 25
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 25
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 23
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 23
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 23
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 17
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000003906 humectant Substances 0.000 claims abstract description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 20
- 235000006708 antioxidants Nutrition 0.000 claims description 16
- 239000004475 Arginine Substances 0.000 claims description 15
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 15
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 15
- 235000009697 arginine Nutrition 0.000 claims description 15
- 229960005070 ascorbic acid Drugs 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 15
- 239000011668 ascorbic acid Substances 0.000 claims description 15
- 239000004359 castor oil Substances 0.000 claims description 15
- 235000019438 castor oil Nutrition 0.000 claims description 15
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 15
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 15
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 15
- HIXYEIRACBUSON-FJXQXJEOSA-N (2s)-2-(3-aminopropanoylamino)-3-(1h-imidazol-5-yl)propanoic acid;hydrochloride Chemical compound Cl.NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 HIXYEIRACBUSON-FJXQXJEOSA-N 0.000 claims description 14
- 108010087806 Carnosine Proteins 0.000 claims description 14
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 14
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 14
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 14
- 229930064664 L-arginine Natural products 0.000 claims description 14
- 235000014852 L-arginine Nutrition 0.000 claims description 14
- 241000736199 Paeonia Species 0.000 claims description 14
- 229940070763 carnosine hydrochloride Drugs 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 14
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 14
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 14
- 229940114123 ferulate Drugs 0.000 claims description 14
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 14
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 230000003750 conditioning effect Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 17
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 17
- 235000002020 sage Nutrition 0.000 abstract description 11
- -1 skin conditioner Chemical compound 0.000 abstract description 10
- 240000007164 Salvia officinalis Species 0.000 abstract description 6
- 235000002912 Salvia officinalis Nutrition 0.000 abstract description 6
- 230000032683 aging Effects 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 230000037394 skin elasticity Effects 0.000 abstract description 3
- 239000000686 essence Substances 0.000 description 44
- 210000003491 skin Anatomy 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 19
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- 241000157282 Aesculus Species 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000017784 Mespilus germanica Nutrition 0.000 description 2
- 244000182216 Mimusops elengi Species 0.000 description 2
- 235000000560 Mimusops elengi Nutrition 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 241001295692 Pyracantha fortuneana Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000007837 Vangueria infausta Nutrition 0.000 description 2
- SHOKSIZSCQFIRY-UHFFFAOYSA-N [3-(2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoyl)oxy-2,2-bis[(2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoyl)oxymethyl]propyl] 2-tert-butyl-2-hydroxy-4,4-dimethyl-3-phenylpentanoate Chemical compound C=1C=CC=CC=1C(C(C)(C)C)C(O)(C(C)(C)C)C(=O)OCC(COC(=O)C(O)(C(C=1C=CC=CC=1)C(C)(C)C)C(C)(C)C)(COC(=O)C(O)(C(C=1C=CC=CC=1)C(C)(C)C)C(C)(C)C)COC(=O)C(O)(C(C)(C)C)C(C(C)(C)C)C1=CC=CC=C1 SHOKSIZSCQFIRY-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 235000010181 horse chestnut Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 229940084032 paeonia lactiflora root extract Drugs 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 244000143590 Salvia chinensis Species 0.000 description 1
- 235000007154 Salvia chinensis Nutrition 0.000 description 1
- 235000005794 Salvia japonica Nutrition 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
Abstract
The invention discloses a whitening and skin-brightening essence and a preparation method thereof, belonging to the technical field of cosmetics, and comprising the following components: solubilizer, humectant, nicotinamide, p-hydroxyacetophenone, skin conditioner, 1, 2-hexanediol, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, tranexamic acid, pH regulator, antioxidant, 1, 3-butanediol, and water. The whitening essence has the advantages that the components in the whitening essence are reasonable in compatibility, the components are mutually influenced and interacted to act from multiple angles of whitening, wherein the paeonia lactiflora extract, the sophorae flavescentis extract and the sage extract have synergistic effect in whitening, and the essence also has the effects of resisting oxidation, resisting aging, nourishing, repairing and improving skin elasticity.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a whitening and skin-brightening essence and a preparation method thereof.
Background
Along with the continuous importance of skin problems such as pigmentation, freckle and the like, whitening becomes an indispensable part of life of people, and various whitening cosmetics are generated for satisfying people's preference and pursuit of fair skin. Traditional whitening agents such as hydroquinone, lead powder and the like have excellent whitening effect, but have large cytotoxicity and strong side effects, and cannot meet the safety required by modern people in pursuing whitening.
CN112807256a discloses a whitening composition and application thereof in cosmetics, which comprises the following components in parts by mass: 0.2 to 2 parts of paeonia lactiflora root extract, 1 to 2 parts of VC ethyl ether and 2 to 5 parts of nonapeptide-1. It is disclosed that paeonia lactiflora root extract can inhibit tyrosinase activity, thereby inhibiting melanin production.
CN108721179a discloses a plant extract composition with whitening effect, a preparation method and application, wherein the composition is composed of extracts of plants of kuh-seng, bamboo leaves, pyracantha fortuneana fruit and medlar; the content of each plant extract is as follows by weight percent: 1 to 34 percent of kuh-seng, 1 to 34 percent of bamboo leaves, 1 to 34 percent of pyracantha fortuneana fruits and 1 to 34 percent of medlar, which discloses that alkaloid components in the kuh-seng can inhibit the activity of tyrosinase in melanocytes, can inhibit the transfer of melanin from melanocytes to horny layer, and has the effect of relieving skin against external stimulus, thereby having the effect of whitening and calming the skin.
CN104013560a discloses a whitening traditional Chinese medicine composition, which comprises the following raw materials in parts by weight: 30-50% of angelica sinensis, 25-35% of rhizoma bletillae, 10-15% of desmodium, 10-15% of sage and 5-10% of liquorice. It discloses sage with bitter, pungent and flat taste, promoting blood circulation to disperse blood clots, dispelling wind and dampness, detoxication and eliminating food retention; the licorice is used for regulating the medicines, has sweet taste, is flat, enters spleen, stomach and lung channels, contains rich glycyrrhetinic acid, licoflavone and other effective whitening and free radical resisting components, and has the effects of invigorating spleen and replenishing qi, clearing heat and detoxicating, whitening and removing freckles.
Although the prior art discloses that the paeonia lactiflora, the kuh-seng and the sage have whitening efficacy, the prior art does not use the paeonia lactiflora, the kuh-seng and the sage in combination for whitening.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a whitening and skin-brightening essence and a preparation method thereof, wherein the essence has an excellent whitening and skin-brightening effect.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
the whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 to 0.25 part of solubilizer, 0.1 to 0.4 part of humectant, 0.2 to 0.6 part of nicotinamide, 0.3 to 0.6 part of p-hydroxyacetophenone, 0.4 to 1 part of skin conditioning agent, 0.4 to 1 part of 1, 2-hexanediol, 0.4 to 1 part of paeonia lactiflora extract, 0.5 to 1.2 part of radix sophorae flavescentis extract, 0.5 to 1.2 part of sage extract, 0.5 to 2 parts of tranexamic acid, 0.5 to 1.2 parts of pH regulator, 1 to 4 parts of antioxidant, 4 to 10 parts of 1, 3-butanediol and 70 to 85 parts of water.
As a preferred embodiment of the present invention, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.15 to 0.25 part of solubilizer, 0.2 to 0.4 part of humectant, 0.3 to 0.6 part of nicotinamide, 0.4 to 0.6 part of p-hydroxyacetophenone, 0.4 to 0.8 part of skin conditioning agent, 0.5 to 1 part of 1, 2-hexanediol, 0.5 to 1 part of paeonia extract, 0.6 to 1.2 part of kuh-seng extract, 0.8 to 1.2 part of sage extract, 0.5 to 1.5 part of tranexamic acid, 0.8 to 1.2 part of pH regulator, 2 to 4 parts of antioxidant, 4 to 8 parts of 1, 3-butanediol and 75 to 85 parts of water.
As a preferred embodiment of the present invention, the whitening and skin-brightening essence comprises the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioning agent, 0.8 part of 1, 2-hexanediol, 0.8 part of radix paeoniae extract, 0.8 part of radix sophorae flavescentis extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water.
As a preferred embodiment of the present invention, the solubilizing agent includes at least one of PEG-40 hydrogenated castor oil, polyglycerol fatty acid ester, fatty alcohol polyoxyethylene ether, polyoxyethylene sorbitan fatty acid ester.
As a preferred embodiment of the present invention, the skin conditioner comprises at least one of tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, panthenol, bioglycol-1, oligopeptide-1, tripeptide-1 copper, palmitoyl pentapeptide-4, horse chestnut saponin, glycosphingolipids.
As a preferred embodiment of the present invention, the pH adjustor comprises at least one of arginine, triethanolamine, citric acid, and sodium citrate.
As a preferred embodiment of the present invention, the antioxidant includes at least one of ascorbic acid, glyceroglycosides, tributyl citrate, pentaerythritol tetrakis (bis-t-butylhydroxyhydrocinnamate), butanol polyether-3.
As a preferred embodiment of the present invention, the humectant comprises at least one of hydrolyzed sodium hyaluronate, glycerin, propylene glycol, oat β -glucan, octylglycol, ethylhexyl glycerin.
The invention also provides a preparation method of the whitening and skin brightening essence, which comprises the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and uniformly stirring at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding solubilizer, peony extract, kuh-seng extract, sage extract and pH regulator, stirring uniformly, and cooling to obtain the whitening and skin-brightening essence.
As a preferred embodiment of the present invention, the stirring rate in the step (1) is 400 to 1000rpm;
the stirring speed in the step (1) is 400-1000 rpm.
The invention has the beneficial effects that: (1) The whitening essence has the advantages that the components in the whitening essence are reasonable in compatibility, the components are mutually influenced and interacted to act from multiple angles of whitening, wherein the paeonia lactiflora extract, the sophorae flavescentis extract and the sage extract have synergistic effect in whitening, and the essence also has the effects of resisting oxidation, resisting aging, nourishing, repairing and improving skin elasticity.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present invention more apparent, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is apparent that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In the invention, the technical characteristics described in an open mode comprise a closed technical scheme composed of the listed characteristics and also comprise an open technical scheme comprising the listed characteristics.
In the present invention, the numerical ranges are referred to as continuous, and include the minimum and maximum values of the ranges, and each value between the minimum and maximum values, unless otherwise specified. Further, when a range refers to an integer, each integer between the minimum and maximum values of the range is included. Further, when multiple range description features or characteristics are provided, the ranges may be combined. In other words, unless otherwise indicated, all ranges disclosed herein are to be understood to include any and all subranges subsumed therein.
In the present invention, the specific dispersing and stirring treatment method is not particularly limited.
The reagents or apparatus used in the present invention are conventional products commercially available without the manufacturer's knowledge.
In order to solve the problem that the prior art has poor whitening and skin brightening effects.
The embodiment of the invention provides a whitening and skin brightening essence, which comprises the following components in parts by mass: 0.1 to 0.25 part of solubilizer, 0.1 to 0.4 part of humectant, 0.2 to 0.6 part of nicotinamide, 0.3 to 0.6 part of p-hydroxyacetophenone, 0.4 to 1 part of skin conditioning agent, 0.4 to 1 part of 1, 2-hexanediol, 0.4 to 1 part of paeonia lactiflora extract, 0.5 to 1.2 part of radix sophorae flavescentis extract, 0.5 to 1.2 part of sage extract, 0.5 to 2 parts of tranexamic acid, 0.5 to 1.2 parts of pH regulator, 1 to 4 parts of antioxidant, 4 to 10 parts of 1, 3-butanediol and 70 to 85 parts of water.
The invention carries out the components according to the specific parts by mass of the raw materials to obtain the essence with excellent whitening and skin brightening effects, and the components in the whitening and skin brightening essence are reasonably compatible, mutually influence and interact to act from multiple angles of whitening, wherein the paeonia lactiflora extract, the sophorae flavescentis extract and the sage extract have synergistic effect in whitening, and the essence also has excellent effects of resisting oxidation, resisting aging, nourishing, repairing and improving skin elasticity.
In the essence, the components with the effects of whitening and brightening skin and the mechanism are mainly as follows:
nicotinamide: acting against the process of melanin transport.
Tranexamic acid: inhibiting melanin-enhanced factor group, thereby thoroughly blocking melanin formation due to ultraviolet irradiation, preventing black spot from thickening and enlarging, and effectively preventing skin pigmentation.
Peony (PAEONIA LACTIFLORA) extract: the paeonia lactiflora extract has the functions of activating skin and resisting aging, can be used for anti-aging cosmetics, has good moisturizing capability, can effectively inhibit the activity of the aminopeptidase, can effectively inhibit the generation of melanin and reduce skin pigmentation.
Kuh-seng (SOPHORA FLAVESCENS) extract: the kuh-seng extract contains various active ingredients such as: matrine, oxymatrine, hydroxy matrine, etc., and radix Sophorae Flavescentis extract has antibacterial and antiinflammatory effects; can effectively promote the generation of collagen, has the effects of resisting aging and preserving moisture, can remove skin endotoxin impurities, has obvious relieving effect on leucocyte reduction caused by cyclophosphamide, X-ray and cobalt-ray irradiation, can effectively inhibit the activity of tyrosinase and the transfer of melanin, and can inhibit the deposition of melanin.
Extracts of Salvia officinalis (Salvia JAPONICA): the sage has excellent anti-inflammatory and sun-proof effects, and can effectively inhibit melanin deposition and improve skin brightness.
The invention takes nicotinamide and tranexamic acid as basic whitening components, and the paeonia lactiflora extract, the sophorae flavescentis extract and the sage extract are added to perform actions from multiple angles of whitening, so that the whitening effect is remarkably improved.
In one embodiment, the whitening and skin brightening essence comprises the following components in parts by mass: 0.15 to 0.25 part of solubilizer, 0.2 to 0.4 part of humectant, 0.3 to 0.6 part of nicotinamide, 0.4 to 0.6 part of p-hydroxyacetophenone, 0.4 to 0.8 part of skin conditioning agent, 0.5 to 1 part of 1, 2-hexanediol, 0.5 to 1 part of paeonia extract, 0.6 to 1.2 part of kuh-seng extract, 0.8 to 1.2 part of sage extract, 0.5 to 1.5 part of tranexamic acid, 0.8 to 1.2 part of pH regulator, 2 to 4 parts of antioxidant, 4 to 8 parts of 1, 3-butanediol and 75 to 85 parts of water.
In one embodiment, the whitening and skin brightening essence comprises the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioning agent, 0.8 part of 1, 2-hexanediol, 0.8 part of radix paeoniae extract, 0.8 part of radix sophorae flavescentis extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water. Particularly, the whitening and skin brightening effects are best at the dosage.
Illustratively, the solubilizing agent includes at least one of PEG-40 hydrogenated castor oil, polyglycerol fatty acid ester, fatty alcohol polyoxyethylene ether, polyoxyethylene sorbitan fatty acid ester.
More specifically, in the whitening and skin-brightening essence of the invention, the solubilizer is preferably PEG-40 hydrogenated castor oil. The solubilizer can improve the compatibility of the whole formula system and is convenient for the dissolution stability of powdery substances in the system.
Illustratively, the skin conditioning agent comprises at least one of tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, panthenol, bioglycol-1, oligopeptide-1, tripeptide-1 copper, palmitoyl pentapeptide-4, horse chestnut saponin, glycosphingolipids.
Illustratively, the pH adjuster includes at least one of arginine, triethanolamine, citric acid, sodium citrate.
More specifically, in the whitening and skin-brightening essence of the invention, arginine is preferably used as the pH regulator.
Illustratively, the antioxidant includes at least one of ascorbic acid, glyceroglycosides, tributyl citrate, pentaerythritol tetrakis (bis-tert-butylhydroxyhydrocinnamate), butanol polyether-3.
More specifically, in the whitening and skin-brightening essence of the present invention, the antioxidant preferably adopts ascorbic acid.
Illustratively, the humectant includes at least one of hydrolyzed sodium hyaluronate, glycerin, propylene glycol, oat beta glucan, caprylic glycol, ethylhexyl glycerin.
More specifically, in the whitening and skin-brightening essence of the invention, the antioxidant preferably adopts hydrolyzed sodium hyaluronate.
The invention also provides a preparation method of the whitening and skin-brightening essence, which comprises the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and uniformly stirring at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding solubilizer, peony extract, kuh-seng extract, sage extract and pH regulator, stirring uniformly, and cooling to obtain the whitening and skin-brightening essence.
As a preferred embodiment of the present invention, the stirring rate in the step (1) is 400 to 1000rpm;
the stirring speed in the step (1) is 400-1000 rpm.
The following examples are provided to facilitate an understanding of the present invention. These examples are not provided to limit the scope of the claims.
Example 1
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 0.8 part of paeonia lactiflora extract, 0.8 part of radix sophorae flavescentis extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps of:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80deg.C and 800 rpm;
(2) Cooling to 45deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain whitening and skin-brightening essence.
Example 2
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.1 part of dipotassium glycyrrhizinate, 0.1 part of L-arginine ferulate, 0.1 part of decarboxylated carnosine hydrochloride, 0.1 part of PEG-40 hydrogenated castor oil, 0.4 part of hydrolyzed sodium hyaluronate, 0.2 part of nicotinamide, 0.6 part of p-hydroxyacetophenone, 0.4 part of 1, 2-hexanediol, 0.4 part of paeonia lactiflora extract, 1.2 parts of radix sophorae flavescentis extract, 0.8 part of sage extract, 1 part of tranexamic acid, 0.8 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 84.7 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps of:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80deg.C and 800 rpm;
(2) Cooling to 45deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain whitening and skin-brightening essence.
Example 3
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.3 part of dipotassium glycyrrhizinate, 0.3 part of L-arginine ferulate, 0.3 part of decarboxylated carnosine hydrochloride, 0.25 part of PEG-40 hydrogenated castor oil, 0.1 part of hydrolyzed sodium hyaluronate, 0.6 part of nicotinamide, 0.3 part of p-hydroxyacetophenone, 1 part of 1, 2-hexanediol, 0.9 part of paeonia lactiflora extract, 0.5 part of radix sophorae flavescentis extract, 1 part of sage extract, 1 part of tranexamic acid, 1.2 parts of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.15 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps of:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80deg.C and 800 rpm;
(2) Cooling to 45deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain whitening and skin-brightening essence.
Example 4
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.15 part of tocopheryl acetate, 0.2 part of dipotassium glycyrrhizinate, 0.25 part of L-arginine ferulate, 0.25 part of decarboxylated carnosine hydrochloride, 0.15 part of PEG-40 hydrogenated castor oil, 0.2 part of hydrolyzed sodium hyaluronate, 0.4 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 0.6 part of paeonia lactiflora extract, 1 part of radix sophorae flavescentis extract, 0.8 part of sage extract, 1.5 parts of tranexamic acid, 1.1 part of arginine, 2 parts of ascorbic acid, 7 parts of 1, 3-butanediol and 83.1 parts of water.
The preparation method of the whitening and skin-brightening essence comprises the following steps of:
(1) Adding nicotinamide, hydrolyzed sodium hyaluronate, p-hydroxyacetophenone, 1, 2-hexanediol, tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, decarboxylated carnosine hydrochloride, tranexamic acid, ascorbic acid and 1, 3-butanediol into water, and stirring at 80deg.C and 800 rpm;
(2) Cooling to 45deg.C, adding PEG-40 hydrogenated castor oil, radix Paeoniae extract, radix Sophorae Flavescentis extract, herba Salvia officinalis extract, and arginine, stirring at 800rpm, and cooling to obtain whitening and skin-brightening essence.
Comparative example 1
Comparative example 1 is different from example 1 in that comparative example 1 does not contain a peony extract, and all others are the same, wherein the amount of the peony extract is replaced with the same amount of the kuh-seng extract and the sage extract, i.e., in this comparative example, the total amount of the peony extract, the kuh-seng extract and the sage extract is unchanged, and all others are the same.
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.2 parts of kuh-seng extract, 1.4 parts of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Comparative example 2
Comparative example 2 is different from example 1 in that comparative example 2 does not contain a kuh-seng extract, but is otherwise identical, in that the amount of the kuh-seng extract is replaced with an equivalent amount of a peony extract, a sage extract, that is, in this comparative example, the total amount of the peony extract, the kuh-seng extract, and the sage extract is unchanged, and is otherwise identical.
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.2 parts of paeonia lactiflora extract, 1.4 parts of sage extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Comparative example 3
Comparative example 3 is different from example 1 in that comparative example 3 does not contain a sage extract, and all the other are the same, wherein the amount of the sage extract is replaced with the same amount of the peony extract, the sophorae flavescentis extract, i.e. in this comparative example, the total amount of the peony extract, the sophorae flavescentis extract, the sage extract is unchanged, and all the other are the same.
The whitening and skin-brightening essence comprises the following components in parts by mass: 0.1 part of tocopheryl acetate, 0.2 part of dipotassium glycyrrhizinate, 0.2 part of L-arginine ferulate, 0.2 part of decarboxylated carnosine hydrochloride, 0.2 part of PEG-40 hydrogenated castor oil, 0.3 part of hydrolyzed sodium hyaluronate, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.8 part of 1, 2-hexanediol, 1.3 parts of paeonia lactiflora extract, 1.3 parts of radix sophorae flavescentis extract, 1 part of tranexamic acid, 1 part of arginine, 3 parts of ascorbic acid, 6 parts of 1, 3-butanediol and 83.4 parts of water.
Test case
35 volunteers (all females, ages between 20 and 28) with no skin abnormality were selected and evenly divided into 7 groups of 5 persons each, and the essences of examples 1 to 4 and comparative examples 1 to 3 were tried out respectively.
Before using the essence, the volunteers clean the face, and collect the brightness (L value) of the face and the individual type angle (ITA DEG value) of the skin color by adopting a skin color test probe (Colorimeter CL 400) as initial values; the volunteers used the essences of examples 1 to 4 and comparative examples 1 to 3 in groups after cleansing the face in the morning and evening, and after 28d of continuous use, the brightness (L value) of the face and the individual skin tone type angle (ITA ° value) were collected by a skin color test probe (Colorimeter CL 400) as test values after the product was tried out and the face was cleansed in the 28d evening, and the brightness and brightness improvement rate was calculated as test values, and the L value/ITA ° value improvement rate= (test value-initial value)/initial value, and the test results are shown in table 1.
TABLE 1
| 28d L value increase rate/% | 28d ITA℃increase rate/% | |
| Example 1 | 3.3 | 5 |
| Example 2 | 2 | 3.8 |
| Example 3 | 2.2 | 3.5 |
| Example 4 | 2.5 | 4.1 |
| Comparative example 1 | 1 | 1.5 |
| Comparative example 2 | 0.7 | 1.1 |
| Comparative example 3 | 0.8 | 1.3 |
As can be seen from table 1, the essence of the present invention has excellent whitening effect, wherein example 1 has the best whitening effect.
Comparative example 1 and comparative examples 1 to 3 show that the paeonia lactiflora extract, the sophorae flavescentis extract and the sage extract have a synergistic effect in whitening and brightening skin.
Finally, it should be noted that the above embodiments are only for illustrating the technical solution of the present invention and not for limiting the scope of the present invention, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made to the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention.
Claims (4)
1. The whitening and skin-brightening essence is characterized by being prepared from the following components in parts by mass: 0.15-0.25 part of solubilizer, 0.2-0.4 part of humectant, 0.3-0.6 part of nicotinamide, 0.4-0.6 part of p-hydroxyacetophenone, 0.4-0.8 part of skin conditioning agent, 0.5-1 part of 1, 2-hexanediol, 0.5-1 part of paeonia extract, 0.6-1.2 part of kuh-seng extract, 0.8-1.2 part of sage extract, 0.5-1.5 part of tranexamic acid, 0.8-1.2 part of pH regulator, 2-4 parts of antioxidant, 4-8 parts of 1, 3-butanediol and 75-85 parts of water;
the solubilizer is PEG-40 hydrogenated castor oil;
the humectant is hydrolyzed sodium hyaluronate;
the antioxidant is ascorbic acid;
the pH regulator is arginine;
the skin conditioner is a mixture of tocopheryl acetate, dipotassium glycyrrhizinate, L-arginine ferulate, and decarboxylated carnosine hydrochloride.
2. The whitening and skin-brightening essence according to claim 1 is characterized by being prepared from the following components in parts by mass: 0.2 part of solubilizer, 0.3 part of humectant, 0.5 part of nicotinamide, 0.5 part of p-hydroxyacetophenone, 0.7 part of skin conditioning agent, 0.8 part of 1, 2-hexanediol, 0.8 part of radix paeoniae extract, 0.8 part of radix sophorae flavescentis extract, 1 part of sage extract, 1 part of tranexamic acid, 1 part of pH regulator, 3 parts of antioxidant, 6 parts of 1, 3-butanediol and 83.4 parts of water.
3. The preparation method of the whitening and skin-brightening essence according to any one of claims 1-2, which is characterized by comprising the following steps:
(1) Adding nicotinamide, humectant, p-hydroxyacetophenone, 1, 2-hexanediol, skin conditioner, tranexamic acid, antioxidant and 1, 3-butanediol into water, and uniformly stirring at 70-85 ℃;
(2) Cooling to 40-50 ℃, adding the solubilizer, the peony extract, the radix sophorae flavescentis extract, the sage extract and the pH regulator, uniformly stirring, and cooling to obtain the whitening and skin-brightening essence.
4. The method for preparing the whitening and skin brightening essence according to claim 3, wherein the stirring rate in the step (1) is 400-1000 rpm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211470574.6A CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211470574.6A CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115671001A CN115671001A (en) | 2023-02-03 |
| CN115671001B true CN115671001B (en) | 2024-03-12 |
Family
ID=85056552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211470574.6A Active CN115671001B (en) | 2022-11-25 | 2022-11-25 | Whitening and skin brightening essence and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115671001B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117297991A (en) * | 2023-03-17 | 2023-12-29 | 广州俏姿颜化妆品有限公司 | Multi-targeting whitening and freckle-removing essence and preparation method thereof |
| WO2024192747A1 (en) * | 2023-03-23 | 2024-09-26 | Elc Management Llc | Cosmetic compositions containing decarboxylated oligopeptide and pyracantha extract and methods for treating lipofuscin |
| CN116650382B (en) * | 2023-07-24 | 2023-12-26 | 广州研智化妆品有限公司 | Tripeptide-1 copper-containing anti-aging repair composition and preparation method and application thereof |
| CN117017820A (en) * | 2023-08-14 | 2023-11-10 | 广州远想生物科技股份有限公司 | Whitening composition and skin care product |
| CN117224444A (en) * | 2023-10-17 | 2023-12-15 | 广州远想生物科技股份有限公司 | Whitening essence and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120129598A (en) * | 2011-05-20 | 2012-11-28 | 이상록 | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage |
| CN106132390A (en) * | 2014-04-03 | 2016-11-16 | 宝丽化成工业有限公司 | The Melanin inhibitor being made up of D pantothenylol and the skin-lightening cosmetic containing this Melanin inhibitor |
| CN110448511A (en) * | 2019-09-06 | 2019-11-15 | 广州留今科学研究有限公司 | The skin conditioning agent of a kind of anticreep adornment and anti-blue light, plain face frost and preparation method thereof |
| CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
| WO2021017835A1 (en) * | 2019-07-30 | 2021-02-04 | 浙江养生堂天然药物研究所有限公司 | Enhanced whitening cosmetic composition |
-
2022
- 2022-11-25 CN CN202211470574.6A patent/CN115671001B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120129598A (en) * | 2011-05-20 | 2012-11-28 | 이상록 | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage |
| CN106132390A (en) * | 2014-04-03 | 2016-11-16 | 宝丽化成工业有限公司 | The Melanin inhibitor being made up of D pantothenylol and the skin-lightening cosmetic containing this Melanin inhibitor |
| WO2021017835A1 (en) * | 2019-07-30 | 2021-02-04 | 浙江养生堂天然药物研究所有限公司 | Enhanced whitening cosmetic composition |
| CN110448511A (en) * | 2019-09-06 | 2019-11-15 | 广州留今科学研究有限公司 | The skin conditioning agent of a kind of anticreep adornment and anti-blue light, plain face frost and preparation method thereof |
| CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115671001A (en) | 2023-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115671001B (en) | Whitening and skin brightening essence and preparation method thereof | |
| CN105662962B (en) | A kind of Whelk-eliminating paste based on high-purity herb extract and preparation method thereof | |
| CN108272862B (en) | Pudilan oral spray and preparation method thereof | |
| CN110638722A (en) | Anti-aging cosmetic and preparation method thereof | |
| CN111529477A (en) | Composition for caring hair, and preparation and application thereof | |
| CN106074306A (en) | A kind of for skin and the compositions of hair maintenance and application | |
| CN111529413A (en) | Nicotinamide capsule mask and preparation and use methods thereof | |
| KR101396438B1 (en) | Composition for improving scalp and hair condition containing the complex extracts of persimmon, camellia sinensis leaf and carob bean | |
| CN111494496A (en) | Traditional Chinese medicine composition for growing and blackening hair and preparation method and application thereof | |
| CN113425639A (en) | Antioxidant composition, application thereof and product | |
| CN110075049B (en) | Traditional Chinese medicine extract and preparation method and application thereof | |
| CN115025024A (en) | Acne and acne mark removing composition and application thereof | |
| CN114796060A (en) | White-to-black essence and preparation method thereof | |
| CN110507572B (en) | Antibacterial and deodorant toothpaste and preparation method thereof | |
| CN109846720B (en) | Tear-type bletilla striata whitening mask and preparation method thereof | |
| CN116407482A (en) | Traditional Chinese medicine whitening, moisturizing and anti-aging face cream and preparation method thereof | |
| CN115227620A (en) | Nourishing and moisturizing skin brightening lotion and preparation method thereof | |
| CN113116765B (en) | Essence stock solution, preparation method thereof and collagenase inhibitor | |
| KR20170136933A (en) | Composition for improving skin condition comprising herb extracts mixture | |
| KR20210143993A (en) | Composition comprising dokdo aster oil | |
| CN110856708A (en) | Facial mask liquid and preparation method thereof | |
| CN109718184A (en) | A kind of combined extracts of plant whitening agent | |
| KR101692910B1 (en) | Composition for relieving seborrheic dermatitis and method for manufacturing thereof | |
| KR101456655B1 (en) | Preventing and Treating Composition for dandruff and itchy scalp | |
| CN114748389B (en) | Essence liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |